ATE35259T1 - Triazinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, welche diese enthalten. - Google Patents

Triazinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, welche diese enthalten.

Info

Publication number
ATE35259T1
ATE35259T1 AT84104295T AT84104295T ATE35259T1 AT E35259 T1 ATE35259 T1 AT E35259T1 AT 84104295 T AT84104295 T AT 84104295T AT 84104295 T AT84104295 T AT 84104295T AT E35259 T1 ATE35259 T1 AT E35259T1
Authority
AT
Austria
Prior art keywords
triazine derivatives
processes
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
AT84104295T
Other languages
English (en)
Inventor
Teraji Tsutomu
Shiokawa Youichi
Okumura Kazuo
Sato Yoshinari
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE35259T1 publication Critical patent/ATE35259T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Color Electrophotography (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT84104295T 1983-04-22 1984-04-16 Triazinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, welche diese enthalten. ATE35259T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58072013A JPS59196874A (ja) 1983-04-22 1983-04-22 トリアジン誘導体
EP84104295A EP0123254B1 (de) 1983-04-22 1984-04-16 Triazinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, welche diese enthalten

Publications (1)

Publication Number Publication Date
ATE35259T1 true ATE35259T1 (de) 1988-07-15

Family

ID=13477098

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84104295T ATE35259T1 (de) 1983-04-22 1984-04-16 Triazinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, welche diese enthalten.

Country Status (15)

Country Link
US (1) US4618610A (de)
EP (1) EP0123254B1 (de)
JP (1) JPS59196874A (de)
KR (1) KR840008341A (de)
AT (1) ATE35259T1 (de)
AU (1) AU2701584A (de)
DE (1) DE3472255D1 (de)
DK (1) DK201684A (de)
ES (3) ES8507517A1 (de)
FI (1) FI841527A (de)
GR (1) GR81788B (de)
HU (1) HU192010B (de)
NO (1) NO841594L (de)
PH (1) PH20020A (de)
ZA (1) ZA842700B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898862A (en) * 1986-03-20 1990-02-06 Sankyo Company Limited 1,2,4-triazinone derivatives, their preparation and use
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
DE4239540A1 (de) * 1992-11-25 1994-05-26 Asta Medica Ag Neue heterocyclische Verbindungen mit antiasthmatischer/antiallergischer, entzündungshemmender, positiv inotroper und blutdrucksenkender Wirkung
DE19929781A1 (de) * 1999-06-29 2001-01-04 Bayer Ag N-[4-(6-Oxotetrahydrotriazinyl)phenyl]amide und ihre Verwendung
EP2532240A3 (de) * 2007-04-03 2013-03-13 E. I. du Pont de Nemours and Company Substituierte Benzenfungizide
EP3661917B1 (de) 2017-08-04 2022-05-11 Bayer Aktiengesellschaft 6-((3-trifluoromethyl)phenyl)-4,5-dihydropyridazin-3(2h)-on-derivate als pde3a and pde3b inhibitoren zur behandlung von krebs
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
EP3917915A1 (de) 2019-02-01 2021-12-08 Bayer Aktiengesellschaft 1,2,4-triazin-3(2h)-on-verbindungen zur behandlung von hyperproliferativen erkrankungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3172252D1 (en) * 1980-11-14 1985-10-17 Ici Plc Heterocyclic compounds
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
GB8310435D0 (en) * 1983-04-18 1983-05-25 Fujisawa Pharmaceutical Co Triazine derivatives

Also Published As

Publication number Publication date
PH20020A (en) 1986-09-01
NO841594L (no) 1984-10-23
FI841527A (fi) 1984-10-23
US4618610A (en) 1986-10-21
JPH0235752B2 (de) 1990-08-13
DK201684D0 (da) 1984-04-18
EP0123254B1 (de) 1988-06-22
HU192010B (en) 1987-04-28
HUT34173A (en) 1985-02-28
DE3472255D1 (en) 1988-07-28
ES539654A0 (es) 1986-04-16
JPS59196874A (ja) 1984-11-08
ZA842700B (en) 1984-11-28
ES531793A0 (es) 1985-09-01
ES8507517A1 (es) 1985-09-01
GR81788B (de) 1984-12-12
ES539653A0 (es) 1985-11-16
ES8602706A1 (es) 1985-11-16
KR840008341A (ko) 1984-12-14
AU2701584A (en) 1984-10-25
DK201684A (da) 1984-10-23
ES8606305A1 (es) 1986-04-16
FI841527A0 (fi) 1984-04-17
EP0123254A1 (de) 1984-10-31

Similar Documents

Publication Publication Date Title
CA2126337A1 (en) 2-amino-1,3-propanediol compound and immunosuppressant
DE69130412D1 (de) Pyrazolopyridinverbindung und Verfahren zu ihrer Herstellung
DE3683403D1 (de) Imidazoheterocyclische verbindungen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
FI974447A (fi) Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet
UA27901C2 (uk) Похідні 7-(2-аміноетил)бензотіазолону, що проявляють агоністичну активність по відношенню до бета2-адренорецепторів, фармацевтична композиція, спосіб їх отримання та проміжні сполуки
FR2684103B1 (fr) Nouveaux composes a structure guanidique et composition pharmaceutique les contenant.
ATE35259T1 (de) Triazinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, welche diese enthalten.
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
ES2001697A6 (es) Procedimiento para preparar 2-aminopurinas sustituidas en posiciones 6 y 9
DE69330601D1 (de) Serotoninergische ergolin derivate
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
IL84802A (en) N-aryl-6,7-dihydro-7-(thi-oxo-(1,2,4)triazolo-(1,5-a)(1,3,5)triazine-2-sulphonamide derivatives and herbicidal and plant growth regulation compositions containing them
FI895139A0 (fi) Pyrrolidinderivat.
ATE21908T1 (de) Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EA199800575A1 (ru) Производные пиперазина

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties